Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Omega 3/6 Fatty Acids for Reading in Children: A Randomised, Double-blind, Placebo-controlled Trial in 9-year-old Mainstream Schoolchildren in Sweden
Brief Summary: The primary objective was to assess whether supplementation of Omega 3/6 fatty acids improves mainstream schoolchildren's reading ability. The secondary objective was to assess whether Omega 3/6 improves cognitive functions such as attention, memory, learning, language/communication, problem solving and social ability.This was a 3-month randomised, double-blind, placebo-controlled study followed by one-way crossover (placebo to active treatment) for an additional 3 months. Mainstream schoolchildren aged 9-10 years were initially randomised to receive three Omega 3/6 capsules twice daily or identical placebo. All outcome measures were assessed at baseline, 3 months and 6 months. The primary outcome measure was the LOGOS test, a comprehensive test battery for evaluating reading abilities. Secondary outcome measures were the parent-rated Attention Deficit Hyperactivity Disorder (ADHD) Rating Scale-IV, 5-15 scale (domains of learning, memory, language/communication and problem solving); Social and Communication Disorders Checklist (to evaluate social ability)


Options:
A: Arm Label: ADHD active; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Eicosapentaenoic acid / Docosahexaenoic acid | Arm Label: ADHD Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo dietary intervention (MUFA) in ADHD group | Arm Label: Active Healthy control; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Eicosapentaenoic acid / Docosahexaenoic acid | Arm Label: Healthy placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo dietary intervention (MUFA) in healthy control group | Intervention Type: DIETARY_SUPPLEMENT; Name: Eicosapentaenoic acid / Docosahexaenoic acid; Assigned to Arm(s): ADHD active | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo dietary intervention (MUFA) in ADHD group; Assigned to Arm(s): ADHD Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Eicosapentaenoic acid / Docosahexaenoic acid; Assigned to Arm(s): Active Healthy control | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo dietary intervention (MUFA) in healthy control group; Assigned to Arm(s): Healthy placebo
B: Intervention Type: DRUG; Name: Phosphatidylserine-Omega3; Assigned to Arm(s): N/A
C: Arm Label: Wheat germ oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Wheat germ oil | Arm Label: docosahexaenoic acid; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: docosahexaenoic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: docosahexaenoic acid; Assigned to Arm(s): docosahexaenoic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Wheat germ oil; Assigned to Arm(s): Wheat germ oil
D: Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega 3/6 fatty acids | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega 3/6 fatty acids; Assigned to Arm(s): Active | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D